Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

Fig. 2

Hierarchical clustering of differentially methylated loci (DML) in Arm A (decitabine + chemotherapy) and Arm B (chemotherapy alone). a unsupervised clustering analysis of 6990 DML in Arm A (left panel) and 1090 DML in Arm B (right panel) revealed separation of end of induction recovering marrows at week 3 from screening marrows. b Unsupervised hierarchical clustering of the top 0.1% most variable loci by standard deviation also separated screening marrows from end of induction recovery marrows at week 3

Back to article page